Used in pharmaceutical research as a key intermediate in the synthesis of kinase inhibitors, particularly those targeting metabolic and inflammatory diseases. Its structure supports high selectivity and binding affinity to specific enzyme targets, making it valuable in developing treatments for type 2 diabetes and non-alcoholic steatohepatitis (NASH). Also explored in preclinical studies for improving insulin sensitivity and glucose homeostasis.